Clinical Trials for Anti-PD-1 Antibody Resistant

Find clinical trials for anti-pd-1 antibody resistant. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma.

NCT ID: NCT04514081

This clinical trial is studying a combination of three medications—Chidamide, Decitabine, and Camrelizumab—to see how well they work for patients with Hodgkin Lymphoma who have not responded to pre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions